Pro-angiogenic therapeutics for preeclampsia

Biology of Sex Differences
Adrian C EddyEric M George

Abstract

Preeclampsia is a pregnancy-induced hypertensive disorder resulting from abnormal placentation, which causes factors such as sFlt-1 to be released into the maternal circulation. Though anti-hypertensive drugs and magnesium sulfate can be given in an effort to moderate symptoms, the syndrome is not well controlled. A hallmark characteristic of preeclampsia, especially early-onset preeclampsia, is angiogenic imbalance resulting from an inappropriately upregulated sFlt-1 acting as a decoy receptor binding vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), reducing their bioavailability. Administration of sFlt-1 leads to a preeclamptic phenotype, and several models of preeclampsia also have elevated levels of plasma sFlt-1, demonstrating its role in driving the progression of this disease. Treatment with either VEGF or PlGF has been effective in attenuating hypertension and proteinuria in multiple models of preeclampsia. VEGF, however, may have overdose toxicity risks that have not been observed in PlGF treatment, suggesting that PlGF is a potentially safer therapeutic option. This review discusses angiogenic balance as it relates to preeclampsia and the studies which have been performed in order to allev...Continue Reading

References

Dec 1, 1992·Kidney International·L F BrownS Rosen
Nov 1, 1990·British Journal of Pharmacology·D D ReesS Moncada
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D MaglioneM G Persico
Jul 1, 1989·British Journal of Obstetrics and Gynaecology·T FruscaA Gastaldi
Apr 1, 1988·American Journal of Obstetrics and Gynecology·D A Davey, I MacGillivray
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R L Kendall, K A Thomas
Sep 1, 1996·Molecular and Cellular Biology·J A ForsytheG L Semenza
Dec 16, 1997·Obstetrics and Gynecology·A RijhsinghaniR A Williamson
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S HiratsukaM Shibuya
Jan 20, 1999·Current Topics in Microbiology and Immunology·M G PersicoT DiPalma
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·A C SchuhK Choi
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·M HidakaA Bernstein
Apr 20, 2001·BMJ : British Medical Journal·J G ErikssonD J Barker
Mar 8, 2002·Hypertension·Robin L DavissonJames N Bates
Sep 24, 2005·Obstetrics and Gynecology·UNKNOWN ACOG Committee on Practice Bulletins--Obstetrics
Dec 13, 2005·Experimental Cell Research·Masabumi Shibuya, Lena Claesson-Welsh
Dec 16, 2005·Nature·Peter Carmeliet
Jan 6, 2006·Kidney International·P K AggarwalV Jha
Apr 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bruna GiganteSandro De Falco
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Anna-Karin OlssonLena Claesson-Welsh
Oct 20, 2006·Nature·Balamurali K AmbatiJayakrishna Ambati
Jan 16, 2007·Stroke; a Journal of Cerebral Circulation·Clive OsmondDavid J P Barker
Mar 23, 2007·Kidney International·A MakrisA Hennessy
Apr 20, 2007·Biophysical Chemistry·Feilim Mac Gabhann, Aleksander S Popel

❮ Previous
Next ❯

Citations

Mar 3, 2020·Frontiers in Physiology·Nozha RaguemaMariane Bertagnolli
Jul 1, 2020·Biomolecules·Manoj Kumar JenaNihar Ranjan Nayak
Nov 25, 2020·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Ali OvayoluNuray Bostancieri
May 26, 2020·Hämostaseologie·Sarah KelliherBarry Kevane
Oct 23, 2020·Heliyon·Cynthia MartinezRaul Díaz-Molina
Dec 31, 2020·Human Reproduction Update·Arthur ColsonAmanda N Sferruzzi-Perri
Apr 3, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Juilee S DeshpandeSadhana R Joshi
Apr 1, 2021·American Journal of Obstetrics and Gynecology·Leslie Myatt
Jun 3, 2021·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Olivia K TravisDenise C Cornelius
Jun 3, 2021·International Journal of Molecular Sciences·Natalia GebaraBenedetta Bussolati
May 25, 2021·Frontiers in Pharmacology·Sylvin Benjamin AtebaLiselotte Krenn

❮ Previous
Next ❯

Methods Mentioned

BETA
ion-exchange chromatography

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy
Patrícia Gonçalves TeixeiraCezar Alencar de Lima Rezende
Annales d'endocrinologie
Edouard Lecarpentier, Vassilis Tsatsaris
Clinica Chimica Acta; International Journal of Clinical Chemistry
Letícia Lemos JardimLuci Maria S Dusse
© 2022 Meta ULC. All rights reserved